Actualités First Trust Cloud Computing Ucits Etf - SKYE | Actions Euronext

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

SkyePharma Makes Senior Appointments

LONDON, Feb. 6 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP)(NASDAQ: SKYE) announces that it has appointed a new senior management team...

SkyePharma PLC - Shareholders Call for Extraordinary General Meeting

LONDON, Jan. 30 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) announces that, further to the announcement issued on 20...

SkyePharma Responds to Call for EGM

LONDON, Jan. 20 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) notes with disappointment the press release issued today by...

SkyePharma Postpones R&D Days

LONDON, Jan. 12 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) announces that because of the ongoing Strategic Review, the...

SkyePharma PLC - Strategic Review Update

LONDON, Jan. 11 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) announces an update on the progress of its Strategic...

SkyePharma R&D Day

LONDON, Oct. 5 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKPLSE: Nasdaq:LSE:SKYE) announces today that its R&D Day meetings, originally...

SkyePharma PLC (LSE: SKP; Nasdaq: SKYE) Announces Interim Financial Results for the Six Months Ended 30 June 2005

LONDON, Sept. 28 /PRNewswire-FirstCall/ -- Operating highlights - US approval and launch of Triglide(TM) (fenofibrate) - New agreement...

SkyePharma Announces Date of Release of Interim Results For The Six Months Ending 30 June 2005

Update On Flutiform(TM) Negotiations LONDON, Sept. 2 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKPLSE: Nasdaq:LSE:SKYE) will announce its...

SkyePharma Reports Preliminary Results Announcement for the Year Ended 31 December 2004

SkyePharma Reports Preliminary Results Announcement for the Year Ended 31 December 2004 LONDON, April 28 /PRNewswire-FirstCall/ -- SkyePharma...

SkyePharma Intends to Increase Equity Stake in Astralis

SkyePharma Intends to Increase Equity Stake in Astralis LONDON, Dec. 14 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE...

SkyePharma Announces US Launch of DepoDur(TM)

SkyePharma Announces US Launch of DepoDur(TM) LONDON, Dec. 6 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) announces today...

SkyePharma Announces Receipt of Milestone Payment for DepoDur(TM)

SkyePharma Announces Receipt of Milestone Payment for DepoDur(TM) LONDON, Oct. 25 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP...

SkyePharma to Present at The Banc of America Securities Specialty Pharamceuticals Conference

SkyePharma to Present at The Banc of America Securities Specialty Pharamceuticals Conference LONDON, July 22 /PRNewswire-FirstCall/...

SkyePharma and AstraZeneca Announce Completion of Phase III Trials of HFA-MDI Version of Pulmicort(R)

SkyePharma and AstraZeneca Announce Completion of Phase III Trials of HFA-MDI Version of Pulmicort(R) LONDON, July 8 /PRNewswire-FirstCall/...

SkyePharma to Present at the Deutsche Bank European Healthcare, Specialty Pharma and Biotech Conference

SkyePharma to Present at the Deutsche Bank European Healthcare, Specialty Pharma and Biotech Conference LONDON, June 10 /PRNewswire-FirstCall/...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

First Trust Cloud Computing Ucits Etf (SKYE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

SKYE Actualités

SkyePharma Makes Senior Appointments

SkyePharma PLC - Shareholders Call for Extraordinary General Meeting

SkyePharma Responds to Call for EGM

SkyePharma Postpones R&D Days

SkyePharma PLC - Strategic Review Update

SkyePharma R&D Day

SkyePharma PLC (LSE: SKP; Nasdaq: SKYE) Announces Interim Financial Results for the Six Months Ended 30 June 2005

SkyePharma Announces Date of Release of Interim Results For The Six Months Ending 30 June 2005

SkyePharma Reports Preliminary Results Announcement for the Year Ended 31 December 2004

SkyePharma Intends to Increase Equity Stake in Astralis

SkyePharma Announces US Launch of DepoDur(TM)

SkyePharma Announces Receipt of Milestone Payment for DepoDur(TM)

SkyePharma to Present at The Banc of America Securities Specialty Pharamceuticals Conference

SkyePharma and AstraZeneca Announce Completion of Phase III Trials of HFA-MDI Version of Pulmicort(R)

SkyePharma to Present at the Deutsche Bank European Healthcare, Specialty Pharma and Biotech Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

First Trust Cloud Computing Ucits Etf (SKYE) Actualités

First Trust Cloud Computing Ucits Etf (SKYE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

SKYE Actualités

SkyePharma Makes Senior Appointments

SkyePharma PLC - Shareholders Call for Extraordinary General Meeting

SkyePharma Responds to Call for EGM

SkyePharma Postpones R&D Days

SkyePharma PLC - Strategic Review Update

SkyePharma R&D Day

SkyePharma PLC (LSE: SKP; Nasdaq: SKYE) Announces Interim Financial Results for the Six Months Ended 30 June 2005

SkyePharma Announces Date of Release of Interim Results For The Six Months Ending 30 June 2005

SkyePharma Reports Preliminary Results Announcement for the Year Ended 31 December 2004

SkyePharma Intends to Increase Equity Stake in Astralis

SkyePharma Announces US Launch of DepoDur(TM)

SkyePharma Announces Receipt of Milestone Payment for DepoDur(TM)

SkyePharma to Present at The Banc of America Securities Specialty Pharamceuticals Conference

SkyePharma and AstraZeneca Announce Completion of Phase III Trials of HFA-MDI Version of Pulmicort(R)

SkyePharma to Present at the Deutsche Bank European Healthcare, Specialty Pharma and Biotech Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités